PHI, Inc.
PHII
PHII was delisted on the 25th of March, 2019.
12 hedge funds and large institutions have $4.94M invested in PHI, Inc. in 2016 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 2 closing their positions.
9% less capital invested
Capital invested by funds: $5.4M → $4.94M (-$465K)
14% less funds holding
Funds holding: 14 → 12 (-2)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citigroup
New York
|
-$183K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$13.3K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$7.62K |
PHII Hedge Fund Activity: Q4 2016 in Review
12 of the 4,001 institutional investors tracked by Wall St. Rank reported a position in PHI, Inc. (PHII) for Q4 2016, worth a combined $4.94M — down 8.6% from $5.4M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of PHII and 0 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 0 added.
The largest seller was Citigroup, exiting entirely with an estimated $183K sold.
- 12 institutional investors held PHI, Inc. (PHII) as of Q4 2016, down from 14 in Q3 2016.
- Funds reported $4.94M of PHI, Inc. stock for Q4 2016, down 8.6% quarter-over-quarter.
- 0 funds opened new PHI, Inc. positions in Q4 2016 and 2 closed out, a net change of -2 holders.
- The largest PHI, Inc. seller in Q4 2016 was Citigroup, an estimated $183K sold.
Based on aggregated 13F filings for Q4 2016.